News | March 08, 2012

Investigational Device Alerts Patients Before Symptoms of Heart Failure Occur

March 8, 2012 — Researchers at Sentara Cardiovascular Research Institute are among the top enrollers out of 69 leading heart centers in the United States involved in a clinical trial designed to use a new investigational device to evaluate the safety and efficacy of a physician-directed patient self-management system.

The purpose of the study is to determine if an implantable monitoring device, smaller than a smart phone, can effectively monitor the pressure in the left atrium of the heart and manage the patient's medications to reduce episodes of heart failure. Heart failure is a chronic condition in which the heart is not pumping as well as it should. Clinicians commonly use the symptoms of heart failure, such as fatigue or shortness of breath, to determine a heart failure patient's status and need for treatment. Left atrial pressure is considered an excellent indicator of status, providing the most objective measure. Changes in left atrial pressure occur before fluid retention and worsening of heart failure symptoms.

In this research study, the device is implanted just under the skin in the chest with wires connected to the heart in half of the study patients. This device records left atrial pressure, and a hand-held monitor collects that information, transmits it to doctors and nurses at the study center over regular phone lines, and directs patients to take medicines or make lifestyle changes as needed. The study is designed to ask patients to increase heart failure medicines to relieve symptoms before they occur.

The study (called Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy, or LAPTOP-HF) is designed to evaluate the rate of heart failure episodes and hospitalizations among the treatment group of heart failure patients and the control group.

"We want to find the body's earliest warning of a heart failure episode even before a patient feels bad or exhibits classic signs of distress like swelling. Our hope is to be able to treat these patients at home, well before a patient needs to come to the hospital," said cardiologist John Herre, M.D., principal investigator and co-medical director at Sentara Cardiovascular Research Institute.

For more information: www.sentara.com

Related Content

Eko Launches Eko Home Cardiac Remote Monitoring Application
News | Remote Monitoring | July 31, 2019
Silicon Valley-based digital health company Eko announced Eko Home, a new service that enables precise remote...
AT&T Demonstrates Connectivity With Smart Scale at HIMSS 2019
News | Remote Monitoring | February 21, 2019
At the recent Healthcare Information and Management Systems Society (HIMSS) annual conference, AT&T’s healthcare...
Ochsner Health System in Louisiana recently announced a new partnership with device data management and remote monitoring vendor Geneva Health Solutions (GHS) for implantable EP cardiac devices.

Ochsner Health System in Louisiana recently announced a new partnership with device data management and remote monitoring vendor Geneva Health Solutions (GHS) for implantable EP cardiac devices. 

News | Remote Monitoring | February 19, 2019
Ochsner Health System in Louisiana recently announced a new partnership with device data management and remote...
Biotronik Named Exclusive U.S. Distributor of MoMe Kardia Diagnostic Monitor
News | Remote Monitoring | September 05, 2018
Biotronik announced it is now the exclusive U.S. distributor for the MoMe Kardia external cardiac diagnostic monitor...
Philips Acquires Xhale Assurance Inc.
News | Remote Monitoring | August 31, 2018
Philips announced it has acquired Xhale Assurance Inc., a U.S.-based scale-up company developing and commercializing...
The Biotricity Bioflux remote ECG monitoring system.
News | Remote Monitoring | July 24, 2018
July 24, 2018 - Diagnostic and consumer healthcare remote monitoring technology company Biotricity Inc.
LindaCare, expansion, remote patient monitoring, CIEDs, cardiac implantable electronic devices, United States
News | Remote Monitoring | January 18, 2017
LindaCare announced that it will open a new customer support facility in Connecticut to support growing interest in...
smartphone application, heart attack detection, University of Turku Finland
News | Remote Monitoring | October 28, 2016
A smartphone application developed by researchers at the University of Turku, Finland, can detect myocardial infarction...
Vital Connect, BePATIENT, BeVITAL remote monitoring system, HealthPatch MD

Vital Connect's HealthPatch MD wearable sensor, part of the BeVITAL remote monitoring system.

Technology | Remote Monitoring | June 08, 2016
Vital Connect Inc., developer of wearable biosensor technologies, and BePATIENT, a startup that develops patient-...
Ambio Health telemonitoring system, LifeBridge Health Cardiovascular Institute, Baltimore, pilot study
News | Remote Monitoring | May 26, 2016
The LifeBridge Health Cardiovascular Institute, Baltimore, has launched a pilot study to evaluate the potential...
Overlay Init